Pharmaceutical/Biotech

Get Rhythm: The Operating Cadence of Integrated Business Planning

September 12, 2019

Does your IBP process have rhythm or arrhythmia?

Eric Deutsch and Timm Reiher answer questions they are frequently asked about the schedule and cadence of Integrated Business Planning (IBP).

The topics covered include:

The typical review meeting schedule
The pre-tasks required to ensure effective reviews
Is it okay to skip reviews
What happens when reviews are combined
The disadvantages of conducting IBP quarterly instead of monthly

After reading this white paper, you will be able to assess the rhythm of your IBP process and whether improvements are needed.

If your company is just starting to operate IBP, you will know the cadence pitfalls to avoid in designing the IBP process.

Trump Plans Crackdown on Fentanyl Shipments From China, Others

September 11, 2019

Bloomberg

A draft executive order would target foreign shippers routing deliveries through the U.S. Postal Service — not the two-largest U.S. couriers United Parcel Service Inc. and FedEx Corp.

THE SCB PODCAST

Podcast | Have We Finally Achieved the End-to-End Supply Chain?

September 6, 2019

Robert J. Bowman, SupplyChainBrain

“The end-to-end supply chain” has been a buzzphrase for decades. Is it finally becoming a reality?

GS1 US Publishes New Implementation Guideline to Help Pharmaceutical Industry Address DSCSA Requirements

September 4, 2019

SupplyChainBrain

GS1 US has published a new Implementation Guideline titled Applying the GS1 Lightweight Messaging Standard for DSCSA Verification of Returned Product Identifiers to help the pharmaceutical industry address impending requirements of the Drug Supply Chain Security Act for verification of saleable returns.

Mass Pig Deaths in China Cause Short Supply of U.S. Blood Thinner

September 3, 2019

Bloomberg

A Chinese outbreak of African swine fever that has killed millions of pigs in the country has also led to falling U.S. supplies of a widely used drug derived from the animals, the anti-clotting drug heparin.

Meeting Pharmaceutical Traceability Requirements Across the Globe

August 7, 2019

DMLogic LLC

Challenge: One of the world’s largest logistics providers was faced with shipping globally sourced drugs from its U.K. distribution centers, and tracking to countries with various regulations was an enormous challenge.

Pentagon Sees Security Threat in China’s Drug-Supply Dominance

August 6, 2019

Bloomberg

The Trump administration sees the increasing use of Chinese-made active ingredients in drugs taken by U.S. troops and civilians as a national security risk.

Solving Pricing Challenges in Healthcare

August 5, 2019

Susan LaFountain, SCB Contributor

Contract price misalignment is among the leading causes of pricing issues in the healthcare supply chain. Price discrepancies are costing healthcare providers more than $92m annually.

Health Agencies Set Stage for U.S. to Import Cheaper Drugs

August 1, 2019

Bloomberg

The Trump administration cracked open the door for the eventual importation of cheaper medicines from abroad, the latest salvo in a battle to bring down drug costs.

Can’t Cope With a Mass of Customer Complaints? AI to the Rescue

July 29, 2019

Robert J. Bowman, SupplyChainBrain

The old days of the Quality movement seem quaint in retrospect: the banners, the slogans, the prizes and team-building events. Today, quality management is all about information — or, more to the point, how to keep from getting buried in it.

Pharmaceutical/Biotech

The latest supply-chain news, analysis, trends and tools for executives in the pharmaceutical and biotech industries. Learn how pharmaceutical and biotech companies and their suppliers around the world are managing the flow of products across all channels of the enterprise. Experts sound off on forecasting and demand planning, supply-chain visibility, logistics outsourcing, inventory optimization, transportation management, warehouse management, supply-chain security, corporate social responsibility and more.